XML 47 R30.htm IDEA: XBRL DOCUMENT v3.26.1
Liquidity and Capital Resources (Details)
1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Nov. 11, 2025
USD ($)
$ / shares
shares
Apr. 30, 2025
USD ($)
$ / shares
shares
Aug. 24, 2022
USD ($)
Feb. 28, 2025
USD ($)
Director
$ / shares
shares
Feb. 28, 2025
USD ($)
Corporation
$ / shares
shares
Mar. 31, 2026
USD ($)
shares
Mar. 31, 2025
USD ($)
shares
Dec. 31, 2025
USD ($)
Aug. 31, 2022
USD ($)
Liquidity [Abstract]                  
Cash and cash equivalents           $ 21,660,496   $ 26,711,969  
Proceeds from issuance of common stock           $ 0 $ 6,994,174    
Proceeds from sale of tax benefits         $ 1,200,000        
Number of New Jersey corporations purchasing tax benefits | Corporation         2        
Sales Agreement [Member]                  
Liquidity [Abstract]                  
Commission paid on Placement Shares sold                 3.00%
Sales Agreement [Member] | Maximum [Member]                  
Liquidity [Abstract]                  
Placement Shares available for sale                 $ 50,000,000
New Sales Agreement [Member]                  
Liquidity [Abstract]                  
Issuance of common stock (in shares) | shares           937,420 205,350    
Proceeds from issuance of common stock           $ 850,000 $ 300,000    
February 2025 Offering [Member]                  
Liquidity [Abstract]                  
Aggregate shares to be sold (in shares) | shares       6,396,787 6,396,787        
Combined purchase price per share and warrant (in dollars per share) | $ / shares       $ 1.5 $ 1.5        
Number of directors participating in securities offering | Director       2          
Gross proceeds from securities offering       $ 11,000,000          
Net proceeds from securities offering       $ 10,050,000.00          
February 2025 Offering [Member] | Directors [Member]                  
Liquidity [Abstract]                  
Aggregate number of shares purchased in securities offering (in shares) | shares       30,121          
Offering price per share (in dollars per share) | $ / shares       $ 1.66 $ 1.66        
February 2025 Offering [Member] | Pre-funded Warrants [Member]                  
Liquidity [Abstract]                  
Number of shares of common stock that can be called by warrants (in shares) | shares       933,334 933,334        
February 2025 Offering [Member] | Common Stock Warrants [Member]                  
Liquidity [Abstract]                  
Number of shares of common stock that can be called by warrants (in shares) | shares       7,330,121 7,330,121        
February 2025 Offering [Member] | Common Stock Warrants [Member] | Directors [Member]                  
Liquidity [Abstract]                  
Number of shares of common stock that can be called by warrants (in shares) | shares       30,121 30,121        
Exercise price of warrants (in dollars per share) | $ / shares       $ 1.53 $ 1.53        
Securities Purchase Agreement [Member]                  
Liquidity [Abstract]                  
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.52              
Term of warrants           10 years      
Securities Purchase Agreement [Member] | Maximum [Member]                  
Liquidity [Abstract]                  
Number of shares of common stock that can be called by warrants (in shares) | shares   1,000,000              
November 2025 Offering [Member]                  
Liquidity [Abstract]                  
Aggregate shares to be sold (in shares) | shares 5,741,000                
Offering price per share (in dollars per share) | $ / shares $ 0.91                
Gross proceeds from securities offering $ 5,300,000                
Net proceeds from securities offering $ 4,800,000                
November 2025 Offering [Member] | Pre-funded Warrants [Member]                  
Liquidity [Abstract]                  
Number of shares of common stock that can be called by warrants (in shares) | shares 59,000                
Offering price per share (in dollars per share) | $ / shares $ 0.9099                
November 2025 Offering [Member] | Common Stock Warrants [Member]                  
Liquidity [Abstract]                  
Number of shares of common stock that can be called by warrants (in shares) | shares 5,800,000                
Exercise price of warrants (in dollars per share) | $ / shares $ 1                
Term of warrants           5 years      
Loan and Security Agreement [Member]                  
Liquidity [Abstract]                  
Proceeds from issuance of secured loans     $ 24,600,000            
Loan repayment   $ 19,000,000              
Debentures [Member]                  
Liquidity [Abstract]                  
Face amount   22,200,000              
Proceeds from issuance   $ 20,000,000              
Loan repayment           $ 1,500,000   $ 2,500,000  
Cash amount used to determine minimum cash balance           15,000,000      
Adjustment to outstanding principal amount of Debentures used to determine minimum cash balance           3,000,000      
Maximum redemption amount per calendar month           $ 500,000